Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer.

Clin Transl Radiat Oncol · 2025 · PMC11788793 · PMID 39901942

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

PSA nadir ≤0.1 ng/mL was a highly significant positive prognostic factor associated with lower risk of BCR (OR = 0.11, 95 % CI: 0.03–0.33; p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.